spatial genomics
Owkin Expands Into Western Europe With Nine Precision Medicine Partnerships
The firm will employ its machine learning-enabled diagnostic and drug discovery tools in nine centers across Germany, Austria, and Switzerland.
The firm has early results from more than 400 cancer samples suggesting the multimodal profiles could aid clinical decision-making and drug target discovery.
AACR Annual Meeting to Showcase Spatial Profiling, AI, New Drug Chemistry in Precision Oncology
Premium
The meeting taking place in San Diego April 5 to 10 will feature early-phase research that may yield new diagnostics and more precise drugs against cancer.
SimBioSys Gains FDA Approval for Spatial Omics Platform in Breast Cancer, Seeks Financing
The TumorSight Viz application aims to make breast cancer treatment planning more precise through 3D tumor images built from standard-of-care medical imaging.
With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer 'Drug Discovery Enterprise'
Premium
The MOSAIC research coalition brings together Owkin, NanoString, and European and US institutions to create a massive spatial omics dataset in pursuit of novel cancer biomarkers